Start for free

Krishna Institute of Medical Sciences Limited

NSE: KIMSHealthcare

Krishna Institute of Medical Sciences Limited Share Price & Analysis

₹764.10−0.49%Updated 4 Sept 2026, 03:30 pm IST
LTP
₹764.10−0.49%
Open
₹769.95
High
₹778.50
Low
₹758.90
Close
₹764.10
52W High
₹858.00
52W Low
₹575.80
Volume
159K
Lot Size
1
Sector
Healthcare
Market Cap
₹32K Cr
Face Value
₹2
Large CapNIFTY 500Nifty Smallcap 250

Price Chart

Candle
Range

Fundamentals

P/E
154.00
Sector P/E
54.70
P/B
13.32
EPS
₹6.03
ROE
11.30%
ROCE
9.50%
D/E Ratio
1.66
Div Yield
0.00%
Book Value
₹56.20

Strengths

    Concerns

    • Premium to sector peers (P/E 154x vs industry 54.7x)
    • High premium to book value (P/B 13.3x)
    • Elevated debt levels (D/E 1.7x)

    Peer Comparison

    CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
    SUNPHARMA
    Sun Pharmaceutical Industries Limited
    ₹1,899
    		₹4.6L Cr36.15.461620.50.07
    DIVISLAB
    Divi's Laboratories Limited
    ₹9,100
    		₹2.4L Cr81.114.4216.5220.01
    TORNTPHARM
    Torrent Pharmaceuticals Limited
    ₹4,857
    		₹1.8L Cr82.819.5827.415.20.33
    APOLLOHOSP
    Apollo Hospitals Enterprise Limited
    ₹8,650
    		₹1.2L Cr59.113.1321.217.40.88
    CIPLA
    Cipla Limited
    ₹1,385
    		₹1.1L Cr31.33.2511.615.50.01
    ZYDUSLIFE
    Zydus Lifesciences Limited
    ₹1,120
    		₹1.1L Cr234.1621.221.10.38
    LAURUSLABS
    Laurus Labs Limited
    ₹1,840
    		₹99K Cr90.918.7418.317.80.46

    Showing 7 peers in the same sector · Sorted by market cap

    Shareholding Pattern

    KIMS · as of Mar 2026

    Promoters38.82%
    FII15.44%0.24pp
    DII31.95%0.10pp
    Public13.78%0.33pp
    CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
    Promoters38.82%38.82%38.82%38.82%38.82%38.82%
    FII15.27%16.73%17.84%15.85%15.68%15.44%
    DII34.24%33.13%32.12%32.29%32.05%31.95%
    Public11.67%11.32%11.22%13.03%13.45%13.78%

    Corporate Events

    To consider and approve the financial results for the period ended Jun 30, 2026

    Results2 Aug 2026

    To consider and evaluate the proposal for raising of funds by way of issuance of one or more instrument(s) / securities which may include equity shares, fully convertible warrants and/or any other eligible securities (convertible / non-convertible) and /

    Event12 Jun 2026

    Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share

    Split12 Sept 2024

    Latest News

    All news

    Krisha Institute gets nod to list ₹19.87M shares via QIP

    *Krishna Institute of Medical Sciences gets SEBI approval for listing 1,98,67,549 shares issued via QIP.* The **19.87 million** equity shares of Rs. 2 each were allocated to qualified institutional buyers. This follows the recent qualified institutional placement aimed at raising capital. Listing these shares enhances liquidity and market visibility. 📊 *STOCKS:* KIMS | 🏢 *SECTOR:* CapitalMarkets | #MEDIUMIMPACT #QIP

    NSE Filing23 Jun
    Medium Impact

    Krishna Institute reports FY26 audited financial results

    *Krishna Institute reports FY26 audited financial results* with standalone and consolidated financial statements released. The filing provides key insights into the company’s performance for the year ended March 31, 2026. Traders will assess revenue, profit margins, and debt levels once figures are available. **No major deviation or surprise indicated** in the headline update. 📊 *STOCKS:* KIMS | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #Earnings

    NSE Filing16 Jun
    Medium Impact

    Financials

    Quarterly Results

    MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    Revenue
    ₹1.1K Cr
    7.7%
    ₹998 Cr
    3.9%
    ₹961 Cr
    10.2%
    ₹872 Cr
    9.4%
    ₹797 Cr
    3.2%
    ₹772 Cr
    0.6%
    ₹777 Cr
    12.9%
    ₹688 Cr
    Op. Profit
    ₹206 Cr
    3.5%
    ₹199 Cr
    2.5%
    ₹204 Cr
    5.7%
    ₹193 Cr
    2.5%
    ₹198 Cr
    5.9%
    ₹187 Cr
    14.2%
    ₹218 Cr
    21.8%
    ₹179 Cr
    OPM
    19.0%
    5.0%
    20.0%
    4.8%
    21.0%
    4.5%
    22.0%
    12.0%
    25.0%
    4.2%
    24.0%
    14.3%
    28.0%
    7.7%
    26.0%
    Net Profit
    ₹33 Cr
    36.5%
    ₹52 Cr
    27.8%
    ₹72 Cr
    15.3%
    ₹85 Cr
    19.8%
    ₹106 Cr
    15.2%
    ₹92 Cr
    24.0%
    ₹121 Cr
    27.4%
    ₹95 Cr
    EPS (₹)
    1.06
    20.3%
    1.33
    20.4%
    1.67
    14.8%
    1.96
    22.8%
    2.54
    14.4%
    2.22
    17.2%
    2.68
    24.1%
    2.16

    Values in ₹ Cr · Source: Screener.in

    Annual Profit & Loss

    MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Revenue
    ₹3.9K Cr
    28.7%
    ₹3.0K Cr
    21.5%
    ₹2.5K Cr
    13.6%
    ₹2.2K Cr
    33.1%
    ₹1.7K Cr
    24.1%
    ₹1.3K Cr
    18.4%
    ₹1.1K Cr
    22.3%
    ₹918 Cr
    38.3%
    ₹664 Cr
    17.1%
    ₹567 Cr
    Expenses
    ₹3.1K Cr
    37.8%
    ₹2.2K Cr
    21.2%
    ₹1.9K Cr
    16.6%
    ₹1.6K Cr
    40.9%
    ₹1.1K Cr
    18.2%
    ₹953 Cr
    9.3%
    ₹872 Cr
    4.7%
    ₹833 Cr
    40.5%
    ₹593 Cr
    31.8%
    ₹450 Cr
    Op. Profit
    ₹815 Cr
    2.8%
    ₹793 Cr
    22.4%
    ₹648 Cr
    6.1%
    ₹611 Cr
    16.6%
    ₹524 Cr
    39.0%
    ₹377 Cr
    50.2%
    ₹251 Cr
    195.3%
    ₹85 Cr
    19.7%
    ₹71 Cr
    39.8%
    ₹118 Cr
    OPM
    21.0%
    19.2%
    26.0%
    0.0%
    26.0%
    7.1%
    28.0%
    12.5%
    32.0%
    14.3%
    28.0%
    27.3%
    22.0%
    144.4%
    9.0%
    18.2%
    11.0%
    47.6%
    21.0%
    Other Income
    ₹17 Cr
    60.5%
    ₹43 Cr
    230.8%
    ₹13 Cr
    68.3%
    ₹41 Cr
    51.9%
    ₹27 Cr
    200.0%
    ₹9 Cr
    80.0%
    ₹5 Cr
    16.7%
    ₹6 Cr
    83.8%
    ₹37 Cr
    1133.3%
    ₹3 Cr
    Interest
    ₹215 Cr
    115.0%
    ₹100 Cr
    81.8%
    ₹55 Cr
    48.6%
    ₹37 Cr
    68.2%
    ₹22 Cr
    40.5%
    ₹37 Cr
    15.9%
    ₹44 Cr
    10.2%
    ₹49 Cr
    44.3%
    ₹88 Cr
    175.0%
    ₹32 Cr
    Depreciation
    ₹283 Cr
    59.9%
    ₹177 Cr
    20.4%
    ₹147 Cr
    14.0%
    ₹129 Cr
    76.7%
    ₹73 Cr
    4.3%
    ₹70 Cr
    1.4%
    ₹71 Cr
    26.8%
    ₹56 Cr
    40.0%
    ₹40 Cr
    14.3%
    ₹35 Cr
    PBT
    ₹334 Cr
    40.1%
    ₹558 Cr
    21.3%
    ₹460 Cr
    5.2%
    ₹485 Cr
    6.1%
    ₹457 Cr
    63.8%
    ₹279 Cr
    97.9%
    ₹141 Cr
    1040.0%
    ₹-15 Cr
    25.0%
    ₹-20 Cr
    137.7%
    ₹53 Cr
    Tax %
    28.0%
    7.7%
    26.0%
    3.7%
    27.0%
    8.0%
    25.0%
    0.0%
    25.0%
    3.8%
    26.0%
    44.4%
    18.0%
    91.9%
    223.0%
    77.0%
    126.0%
    240.5%
    37.0%
    Net Profit
    ₹242 Cr
    41.7%
    ₹415 Cr
    23.5%
    ₹336 Cr
    8.2%
    ₹366 Cr
    6.4%
    ₹344 Cr
    67.8%
    ₹205 Cr
    78.3%
    ₹115 Cr
    334.7%
    ₹-49 Cr
    6.5%
    ₹-46 Cr
    239.4%
    ₹33 Cr
    EPS (₹)
    6.03
    37.3%
    9.61
    24.0%
    7.75
    7.8%
    8.41
    1.1%
    8.32
    60.3%
    5.19
    62.2%
    3.2
    350.0%
    -1.28
    3.0%
    -1.32
    245.1%
    0.91
    Div Payout
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%

    Values in ₹ Cr · Source: Screener.in

    Balance Sheet

    ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Liabilities
    Equity Capital
    ₹80 Cr
    0.0%
    ₹80 Cr
    0.0%
    ₹80 Cr
    0.0%
    ₹80 Cr
    0.0%
    ₹80 Cr
    2.6%
    ₹78 Cr
    5.4%
    ₹74 Cr
    0.0%
    ₹74 Cr
    48.0%
    ₹50 Cr
    30.6%
    ₹72 Cr
    Reserves
    ₹2.2K Cr
    5.3%
    ₹2.1K Cr
    17.7%
    ₹1.7K Cr
    9.9%
    ₹1.6K Cr
    21.7%
    ₹1.3K Cr
    66.3%
    ₹786 Cr
    50.0%
    ₹524 Cr
    12.4%
    ₹466 Cr
    323.0%
    ₹-209 Cr
    182.0%
    ₹255 Cr
    Borrowings
    ₹4.3K Cr
    66.0%
    ₹2.6K Cr
    89.1%
    ₹1.4K Cr
    99.9%
    ₹678 Cr
    163.8%
    ₹257 Cr
    18.7%
    ₹316 Cr
    14.4%
    ₹369 Cr
    9.8%
    ₹336 Cr
    55.4%
    ₹753 Cr
    168.9%
    ₹280 Cr
    Other Liabilities
    ₹1.2K Cr
    20.2%
    ₹990 Cr
    55.7%
    ₹636 Cr
    15.0%
    ₹553 Cr
    112.7%
    ₹260 Cr
    2.8%
    ₹253 Cr
    11.0%
    ₹228 Cr
    3.8%
    ₹237 Cr
    34.0%
    ₹359 Cr
    115.0%
    ₹167 Cr
    Total Liabilities
    ₹7.7K Cr
    35.2%
    ₹5.7K Cr
    48.9%
    ₹3.8K Cr
    31.7%
    ₹2.9K Cr
    52.4%
    ₹1.9K Cr
    32.9%
    ₹1.4K Cr
    20.0%
    ₹1.2K Cr
    7.2%
    ₹1.1K Cr
    16.8%
    ₹954 Cr
    23.3%
    ₹774 Cr
    Assets
    Fixed Assets
    ₹5.7K Cr
    70.5%
    ₹3.3K Cr
    37.6%
    ₹2.4K Cr
    37.8%
    ₹1.8K Cr
    75.7%
    ₹1.0K Cr
    7.9%
    ₹931 Cr
    1.6%
    ₹916 Cr
    6.1%
    ₹863 Cr
    14.3%
    ₹755 Cr
    45.8%
    ₹518 Cr
    CWIP
    ₹606 Cr
    50.1%
    ₹1.2K Cr
    102.3%
    ₹600 Cr
    25.8%
    ₹477 Cr
    2171.4%
    ₹21 Cr
    133.3%
    ₹9 Cr
    350.0%
    ₹2 Cr
    ₹0 Cr
    ₹0 Cr
    100.0%
    ₹64 Cr
    Investments
    ₹103 Cr
    4.0%
    ₹99 Cr
    36.9%
    ₹157 Cr
    130.9%
    ₹68 Cr
    79.5%
    ₹332 Cr
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    100.0%
    ₹14 Cr
    Other Assets
    ₹1.3K Cr
    23.6%
    ₹1.0K Cr
    63.4%
    ₹629 Cr
    6.6%
    ₹590 Cr
    8.1%
    ₹546 Cr
    10.8%
    ₹493 Cr
    78.6%
    ₹276 Cr
    10.4%
    ₹250 Cr
    25.6%
    ₹199 Cr
    12.4%
    ₹177 Cr
    Total Assets
    ₹7.7K Cr
    35.2%
    ₹5.7K Cr
    48.9%
    ₹3.8K Cr
    31.7%
    ₹2.9K Cr
    52.4%
    ₹1.9K Cr
    32.9%
    ₹1.4K Cr
    20.0%
    ₹1.2K Cr
    7.2%
    ₹1.1K Cr
    16.8%
    ₹954 Cr
    23.3%
    ₹774 Cr

    Values in ₹ Cr · Source: Screener.in

    Cash Flow Statement

    ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Operating CF
    ₹511 Cr
    12.2%
    ₹582 Cr
    11.7%
    ₹521 Cr
    20.6%
    ₹432 Cr
    33.3%
    ₹324 Cr
    9.0%
    ₹356 Cr
    76.2%
    ₹202 Cr
    50.7%
    ₹134 Cr
    26.4%
    ₹106 Cr
    29.3%
    ₹82 Cr
    Investing CF
    ₹-1.5K Cr
    30.1%
    ₹-1.1K Cr
    48.2%
    ₹-753 Cr
    81.0%
    ₹-416 Cr
    1.0%
    ₹-412 Cr
    16.4%
    ₹-354 Cr
    183.2%
    ₹-125 Cr
    13.6%
    ₹-110 Cr
    71.9%
    ₹-64 Cr
    36.0%
    ₹-100 Cr
    Financing CF
    ₹940 Cr
    73.1%
    ₹543 Cr
    150.2%
    ₹217 Cr
    985.0%
    ₹20 Cr
    67.2%
    ₹61 Cr
    510.0%
    ₹10 Cr
    122.7%
    ₹-44 Cr
    63.0%
    ₹-27 Cr
    30.8%
    ₹-39 Cr
    262.5%
    ₹24 Cr
    Net Cash Flow
    ₹-1 Cr
    111.1%
    ₹9 Cr
    160.0%
    ₹-15 Cr
    141.7%
    ₹36 Cr
    238.5%
    ₹-26 Cr
    316.7%
    ₹12 Cr
    62.5%
    ₹32 Cr
    1166.7%
    ₹-3 Cr
    200.0%
    ₹3 Cr
    40.0%
    ₹5 Cr
    Free Cash Flow
    ₹-902 Cr
    137.4%
    ₹-380 Cr
    204.0%
    ₹-125 Cr
    10.7%
    ₹-140 Cr
    190.9%
    ₹154 Cr
    41.2%
    ₹262 Cr
    74.7%
    ₹150 Cr
    163.2%
    ₹57 Cr
    16.3%
    ₹49 Cr
    372.2%
    ₹-18 Cr

    Values in ₹ Cr · Source: Screener.in

    Key Ratios History

    MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Debtor Days
    52d
    8.3%
    48d
    11.6%
    43d
    2.4%
    42d
    50.0%
    28d
    6.7%
    30d
    30.2%
    43d
    12.2%
    49d
    16.9%
    59d
    0.0%
    59d
    Inventory Days
    —
    —
    —
    —
    37d
    23.3%
    30d
    31.8%
    44d
    6.4%
    47d
    2.2%
    46d
    7.0%
    43d
    Days Payable
    —
    —
    —
    —
    133d
    20.4%
    167d
    5.6%
    177d
    2.2%
    181d
    15.8%
    215d
    3.9%
    207d
    Cash Conv. Cycle
    52d
    8.3%
    48d
    11.6%
    43d
    2.4%
    42d
    162.7%
    -67d
    36.8%
    -106d
    16.5%
    -91d
    7.1%
    -85d
    22.7%
    -110d
    4.8%
    -105d
    Working Capital Days
    -37d
    27.6%
    -29d
    480.0%
    -5d
    162.5%
    8d
    366.7%
    -3d
    90.3%
    -31d
    106.7%
    -15d
    0.0%
    -15d
    95.5%
    -333d
    1380.8%
    26d
    ROCE
    10.0%
    33.3%
    15.0%
    11.8%
    17.0%
    29.2%
    24.0%
    29.4%
    34.0%
    17.2%
    29.0%
    45.0%
    20.0%
    300.0%
    5.0%
    54.5%
    11.0%
    26.7%
    15.0%

    Source: Screener.in · Lower days = better efficiency

    About Krishna Institute of Medical Sciences Limited

    Krishna Medical Institution Ltd (KIMS) was Incorporated in the year 1973 and is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered. The company offers multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities and an additional quaternary healthcare facility in tier-1 cities.

    HealthcareHealthcare Services

    Related Analysis

    Same Sector

    ALKEMAlkem Laboratories LimitedNeutralAPOLLOHOSPApollo Hospitals Enterprise LimitedNeutralAUROPHARMAAurobindo Pharma LimitedNeutralBIOCONBiocon LimitedNeutralCIPLACipla LimitedNeutral

    Frequently Asked Questions

    What is Krishna Institute of Medical Sciences Limited share price today?
    Krishna Institute of Medical Sciences Limited (KIMS) is currently trading at ₹764.1 on NSE, down 0.49% as of the last market session. Prices update daily after market close on MarketNetra.
    Is Krishna Institute of Medical Sciences Limited available in F&O (Futures & Options)?
    Yes, Krishna Institute of Medical Sciences Limited (KIMS) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
    What is Krishna Institute of Medical Sciences Limited 52-week high and low?
    Krishna Institute of Medical Sciences Limited's 52-week high is ₹858 and the 52-week low is ₹575.8. The current price of ₹764.1 is 10.9% below the 52W high.
    What is Krishna Institute of Medical Sciences Limited P/E ratio?
    Krishna Institute of Medical Sciences Limited's current P/E ratio is 154. This indicates the market is paying ₹154 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
    How to trade Krishna Institute of Medical Sciences Limited options?
    Krishna Institute of Medical Sciences Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade KIMS options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.